antibody-granulocyte colony-stimulating factor (G-CSF) conjugates (Immunomedics/IBC)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameantibody-granulocyte colony-stimulating factor (G-CSF) conjugates (Immunomedics/IBC)
Drug Alias NameG-CSF-h734G-CSF-labetuzumabG-CSF-veltuzumabIgG-G-CSF conjugates (Imuunomedics)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionCarcinoembryonic antigen related cell adhesion molecule 5 modulatorsB-lymphocyte antigen CD20 modulatorsColony stimulating factor 3 receptor agonists
TargetsB-lymphocyte antigen CD20Colony stimulating factor 3 receptorCarcinoembryonic antigen related cell adhesion molecule 5
Therapy Area/IndicationsNeutropeniaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmunomedics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIbc Pharmaceuticals IncImmunomedics Inc
Active IndicationsN/A
Inactive IndicationsNeutropeniaNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A